SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms.
Nikolic M, Zivkovic V, Jovic JJ, Sretenovic J, Davidovic G, Simovic S, Djokovic D, Muric N, Bolevich S, Jakovljevic V.
Nikolic M, et al. Among authors: jakovljevic v.
Heart Fail Rev. 2022 May;27(3):935-949. doi: 10.1007/s10741-021-10079-9. Epub 2021 Feb 3.
Heart Fail Rev. 2022.
PMID: 33534040
Review.